Trump administration invests $4.9 million to research psychedelic as PTSD treatment
Posted
Courtenay Harris Bond (via PhillyVoice)
The Trump administration is investing $4.9 million into studying the psychedelic ibogaine as a potential treatment for PTSD and other serious mental health issues. The drug has shown potential, but it also carries risk of abnormal heart rhythms and death.
